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The renin–angiotensin system (RAS) has been shown to
be involved in many cardiovascular diseases. Carriers
of the D-allele of the angiotensin converting enzyme
(ACE) insertion/deletion (I/D) polymorphism display
elevated serum and cardiac ACE activity, and thus may
have higher RAS system activation [1,2]. Therefore,
D-allele carriers are exposed to a higher intracardiac
angiotensin II level causing myocardial fibrosis and
repolarization abnormalities, which might partially
explain why the ACE I/D polymorphism was associ-
ated with an increased magnitude of QT dispersion
(QTd) prolongation in our previous cohort study [3].
A genetic variant -6G > A in the proximal promoter
region of the angiotensinogen (AGT) gene, a guanine
to adenine substitution 6 base pairs (bp) before the
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Ventricular repolarization abnormality plays a crucial role in cardiac arrhythmia. Polymorphisms
in renin–angiotensin system genes are associated with occurrence of ventricular arrhythmia. We
previously demonstrated that subjects carrying the angiotensin converting enzyme (ACE) D-allele
but not the angiotensinogen (AGT) M235T polymorphism had a higher magnitude of QT dispersion
(QTd) prolongation. The aim of this study was to test whether the AGT [-6G > A] and angiotensin
II type 1 receptor (AT1R) [1166A > C] polymorphisms influence repolarization parameters,
including QTd and the peak and end of the T wave interval (Tpe). Of 1,500 people screened, 106
normotensive, non-diabetic participants aged ≥ 60 were recruited. ECGs were recorded at baseline
and in the second and fourth years. QTd and Tpe were manually calculated. Gene polymorphisms
were analyzed by polymerase chain reaction. Mean age was 72.7 ± 4.1 years (range, 62–81 years).
QTd and Tpe were significantly prolonged in the second and fourth years (all p < 0.001). Neither
gene polymorphism was associated with the magnitudes of QTd and Tpe prolongations. This
longitudinal study shows that the AT1R [1166A > C] and AGT [-6G > A] polymorphisms do not
influence repolarization parameters in this Chinese population in Taiwan, and so are not suitable
markers to identify individuals susceptible to changes in these parameters.
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site of transcription initiation, has been reported to
affect the basal transcription rate of the AGT gene [4,5].
Because chronic angiotensin II stimulation was found
to produce QT prolongation, this potentially functional
variant may modulate repolarization parameters [6].
The angiotensin II type 1 receptor (AT1R) mediates
most of the actions of angiotensin II. A polymorphism
in the 3 untranslated region of the gene encoding
human AT1R, corresponding to an A to C transver-
sion at position 1166 [1166A > C], has been identified
[7]. This polymorphism contributes to heart-rate cor-
rected QT (QTc) prolongation in a majority of end-
stage renal disease patients [8]. In patients with
coronary artery disease, the risk of malignant ven-
tricular arrhythmias was reported to be higher in
individuals homozygous for both AT1R C-alleles [9].
The frequency of arrhythmia increases with age,
probably due to age-associated degenerative changes
in the conduction system and myocardial fibrosis [10].
Ventricular repolarization abnormalities play an im-
portant role in the occurrence of arrhythmia. The QT
interval and QTd, two repolarization parameters, are
prolonged with increasing age, which may contribute
to an increased risk of ventricular arrhythmias and
cardiac mortality among elderly patients [11]. Several
large prospective studies have assessed the predictive
value of QTd for cardiac and all-cause mortality [12].
Their results suggested that a long QTd is associated
with high cardiovascular morbidity and mortality.
More recently, transmural dispersion of repolarization
(TDR) has been evaluated by measuring the interval
between the peak and the end of the T wave (Tpe) and
the Tpe/QT ratio, two new repolarization parameters
[13,14]. These additional TDR-related parameters were
found to be associated with the occurrence of arrhyth-
mia, such as torsades de pointes in long QT syndrome
[14]. Furthermore, a cross-sectional study showed
that TDR parameters were found to increase with 
age [15]. Therefore, it is important to identify risk 
factors that may predispose elderly individuals to 
prolongation of these repolarization parameters.
We previously found that aging was associated
with prolongation of the QT interval and QTd in
healthy elderly [16]. Furthermore, we demonstrated
that subjects carrying the ACE D-allele had a higher
magnitude of QTd and corrected QT dispersion (QTcd)
prolongation [3]. In the present study, we proposed
to test for a relationship between the magnitudes of
QTd, Tpe and Tpe/QT prolongations and two genetic




Subjects were recruited from a community-based
longitudinal cohort study (Gerontology Research
Laboratory: The Longitudinal Study of Aging),
which was designed to discover changes in several
physiologic functions and structures with the aging
process in healthy elderly subjects. This working
group was first initiated in 2000 and included several
co-investigators specializing in chest medicine, ortho-
pedics and cardiology. Each co-investigator physician
was responsible for one specific examination of the
elderly participants. Each participant had to be free
of disease at baseline in order to be recruited into the
normal aging group. Participants were invited from
several senior activity centers in Kaohsiung city,
Taiwan. Baseline examinations were performed from
October 1, 2000 to March 31, 2001.
The screening process included three stages. The
Figure demonstrates the numbers of participants at
each stage of screening or examination. There were
1,500 potential candidates at the beginning. After being
interviewed by senior nurses using a constructed
questionnaire, 694 of the 1,500 candidates were quali-
fied to enter into the study. However, only 434 elderly
candidates were willing to visit Kaohsiung Medical
University Hospital (KMUH) to undergo biochemical
tests and physical examinations at the first stage. The
results of the laboratory tests and chest X-rays were
carefully examined by two senior physicians. Among
them, 254 candidates qualified as healthy elderly,
while 180 did not meet the criteria. At the second stage,
221 of 254 subjects continued to participate in the study
for bone density (BD) evaluation. BD evaluation ex-
cluded seven unqualified subjects and six subjects
were lost to follow-up. Finally, only 208 subjects partic-
ipated in the third-stage examinations of electrocardio-
graphy (ECG) and echocardiography. Among these,
193 cases had normal ECG and echocardiographic data
and were enrolled into the cardiology study popu-
lation, while 15 cases did not meet the criteria. The
inclusion criteria for healthy elderly subjects in cardi-
ology were: (1) age ≥ 60 years; (2) active lifestyle, with
no limitations in daily life; (3) no history of previously
diagnosed diabetes, hypertension, ischemic heart dis-
ease or cerebrovascular accident; (4) no significant
ECG or echocardiographic abnormality including
atrial fibrillation and myocardial infarction; and (5)
not on any chronic medications. This study was ap-
proved by the Institutional Review Board of KMUH.
All enrolled patients gave their informed consent.
Blood pressures were taken after the individuals
had rested comfortably for 10minutes. A computerized
automatic mercury-sphygmomanometer (CH-5000;
Citizen, Tokyo, Japan) was used on the right arm, with
participants in a seated position. The reading was
repeated and the mean of these two readings was used.
Hypertension was defined as a systolic blood pressure
≥140mmHg or a diastolic blood pressure ≥90mmHg.
Body weight and height were measured, and the body
mass index (BMI) was calculated. All measurements
were repeated every 2 years. The examinations were
usually scheduled in the same month as the first visit to
ensure the same interval of follow-up.
ECG
A standard 12-lead resting ECG was recorded at a pa-
per speed of 25 mm/s and a gain of 10 mm/mV, at
baseline and in years 2 and 4. To reduce the impact of
circadian variations in QTd, ECG examinations were
completed in the morning (8 to 10 A.M.). All ECGs,
with those at the same observational stage as a group,
were analyzed manually by a single experienced car-
diologist (H.S.) blinded to the clinical data. Subjects
with complete bundle branch block, second or third
degree atrioventricular block, or less than nine 
measurable leads in the ECG were excluded.
The QT was defined as the interval between the
QRS onset and the end of the T wave, at the point
where the isoelectric line intersected a tangential line
drawn on the maximal downslope of the positive T
wave [17]. QT interval was corrected (QTc) according
to the Bazett’s formula. QTd was calculated as the max-
imal QT minus the minimal QT interval. The interval
between the peak and the end of the T wave (Tpe) was
measured using the V5 lead [18]. Tpe/QT was calcu-
lated as the relative Tpe interval divided by the QT
interval in the V5 lead. All measurements represent
the mean of approximately 3 consecutive beats.
Prolongation of QTd was defined as QT dispersion
at years 2 and 4 minus QT dispersion at baseline. Pro-
longations of Tpe and Tpe/QT were calculated in the
same way. The left ventricle (LV) was measured by
echocardiography. LV mass was calculated according
to the formula of Devereux and Reichek [19], and then
divided by body surface area as a LV mass index
(LVMI) used in the present study.
Extraction and amplification of 
genomic DNA
In accordance with standard methodology, genomic
DNA was extracted from peripheral blood using 
a blood DNA kit (Puregene Gentra System,
Minneapolis, USA). Genomic DNA was suspended
in 10 mmol/L Tris-HCl, 1 mmol/L EDTA pH 8.0, and
the concentrations of DNA were determined by 
spectrophotometry.
The AGT [-6G > A] and AT1R [1166A > C] polymor-
phisms were analyzed by polymerase chain reaction,
as previously described [20,21].
Statistical analysis
All data are expressed as mean ± standard deviation
(SD). Paired t tests were used to evaluate changes 
in continuous variables during the 4-year follow-up.
The genotypic distribution was tested by Hardy-
Weinberg equilibrium. Independent t tests were used
for analysis of continuous variables. We used ANOVA
to test baseline and follow-up variables among the
different genotypes. Pair-wise comparisons between
any two of the three genotypes were performed using
Scheffé’s method. All tests were two-sided, and the
level of significance was established as p < 0.05. SPSS
version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows
was used for statistical analysis.
RESULTS
Clinical characteristics
A total of 193 subjects were enrolled initially. As shown
in the Figure, 132 completed 4 years of ECG and echo-
cardiography examinations. One hundred and fifteen
subjects provided blood for genetic analysis, but nine
were excluded because of uninterpretable ECGs or re-
striction digest results in genotypes. A total of 106 sub-
jects were included in the current study. Table 1
summarizes the demographic information at baseline,
and in the second and fourth years. The subjects
included 81 men and 25 women. Age at enrolment
ranged from 62 to 81 years (mean, 72.7±4.1 years). At
the end of the 4-year follow-up, weight and height
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were significantly reduced. There was an increase in
LVMI (97.9±25.4 to 105.9±29.7g/m2, p=0.001) at the
third examination (Table 1). No significant arrhythmia
was found during the follow-up period. Two subjects
suffered from asymptomatic atrial premature beats
and one suffered from asymptomatic ventricular pre-
mature beats in the second year. ECGs showed atrial
premature beats in another two participants and ven-
tricular premature beats in one in the fourth year.
There were no statistically significant differences in
baseline characteristics, including sex (male, 75% vs.
84%, p=0.159), age (72.7±4.4 years vs. 73.7±3.2 years,
p=0.087), BMI (23.3±3.1kg/m2 vs. 23.0±3.1kg/m2,
p = 0.453), LVMI (162.4 ± 45.3 g/m2 vs. 165.9 ± 51.3 g/
m2, p=0.621), or systolic (125.1±14.1mmHg vs. 127.5±
13.2mmHg, p=0.230) and diastolic (71.9±8.8mmHg
vs. 73.2±9.6mmHg, p=0.348) blood pressures, be-
tween subjects completing 4-year follow-up and those
who did not.
AGT [-6G>A] and AT1R [1166A>C]
polymorphisms
Among the 106 study subjects, one (0.9%) had an AA
genotype at position 1166 of the AT1R gene, 13 (12.3%)
had a CA genotype and 92 (86.8%) had a CC genotype.
Three (2.8%) had a GG genotype at position -6 of the
AGT gene, 32 (30.2%) had a GA genotype and 71
(67.0%) had an AA genotype. Since the frequency of the
AT1R AA genotype was very low, the AA and CA geno-
types were categorized into one group for analysis, as
were the GG and GA genotypes in the AGT gene. The
genotypic distribution was in Hardy-Weinberg equilib-
rium in both genes. There was no significant difference
among the AT1R or AGT genotypes regarding baseline
age, BMI, systolic and diastolic blood pressures, and
LVMI (Tables 2 and 3). The AT1R and AGT genotypes
were not correlated with QTc and QTd at baseline, or in
year 2 or 4. Neither gene polymorphism was correlated
with Tpe and Tpe/QT at baseline, or in years 2 and 4.
ECG follow-up data
The QTc interval, QTd, Tpe and Tpe/QT increased
during the follow-up period (Table 1). In the second
and fourth years, AT1R and AGT gene polymor-
phisms were not associated with QTd at baseline, in
year 2 or year 4. Prolongations of QT dispersion, Tpe
and Tpe/QT were not related to either genotype in
years 2 or 4 (Tables 2 and 3).
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Preliminary screening n = 1,500
Stage 2: Bone density examination n = 221
Qualified subjects at baseline (Year 2000) n = 193
Subjects at the second visit (Year 2002) n = 170
Stage 3: ECG and echocardiography n = 208
Subjects at the third visit (Year 2004) n = 144
Qualified n = 694
Normal n = 254
Abnormal n = 15
Abnormal n = 7
Abnormal n = 180
Normal n = 214
Normal n = 193
Loss of follow-up total n = 23
Reject n = 16
Acute illness n = 1
Family issues n = 2
Wrong address/telephone n = 2
Death n = 2
Loss of follow-up total n = 26
Acute illness n = 2
Moved out n = 3
Wrong address/telephone n = 7
Loss of contact n = 12
Death n = 2
Loss of follow-up n = 6
Loss of follow-up n = 33
Reject further evaluation
n = 260
Reject ECG or echocardiography
n = 12
Stage 1: Laboratory and chest X-ray
examination n = 434
Complete 4 years ECG and echocardiography
n = 132
Screening failure n = 806
Figure. Trial profile.
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DISCUSSION
We have found that the aging process was associated
with prolongations in the QTc interval and QTd in
healthy elderly subjects, and subjects carrying the ACE
D-allele have a higher magnitude of QTd prolongation
[3,17]. In the present study, we found that the AGT
[-6G > A] and AT1R [1166A > C] polymorphisms were
not associated with these repolarization parameters or
their changes.
Histopathologic evaluation has revealed a mal-
adaptive remodeling of the interstitium associated
with aging, resulting in an increase in patchy myocar-
dial fibrosis, cardiac hypertrophy and changes in
repolarization variables [22,23]. In a previous cross-
sectional study, the QT interval and TDR parameters
were found to be prolonged with increasing age,
which may partially explain the increased risk of
ventricular arrhythmias and cardiac mortality in 
the elderly population [10,15]. Our study further
demonstrated that aging is associated with the pro-
longation of repolarization parameters among those
aged ≥ 60 years in a prospective cohort. Several large
prospective studies have reported that cardiac repo-
larization parameters, such as QTd, can be deter-
minants of cardiac and all-cause mortality [12].
Therefore, it is mandatory to seek risk factors that
may predispose to prolongation of these repolariza-
tion parameters in the elderly in a longitudinal
study.
Cardiac hypertrophy and fibrosis are associated
with a significant change in the transmembrane action
potential that results in the prolongation of QT vari-
ables [22]. Since angiotensin II exerts direct actions on
cardiac tissue, inducing cardiomyocyte hypertrophy
and electromechanical dysfunction, the generation of
this peptide may be of the highest clinical importance
[24]. A genetic variant -6G>A in the proximal promoter
region of the angiotensinogen (AGT) gene, a guanine
to adenine substitution 6 bp from the site of transcrip-
tion initiation, has been reported; it appears that this
GA substitution affects the basal transcription rate
of the AGT gene [5,6]. Because chronic angiotensin II
stimulation in the heart was found to produce QT
prolongation, this potentially functional variant may
modulate repolarization parameters [7]. Furthermore,
angiotensin II modulates ventricular repolarization
by a direct effect on the ion channels of the ventricular
myocyte, possibly leading to changes in repolarization
parameters [25]. In our prospective study, we found
there was no association between the AGT [-6G > A]
polymorphism and repolarization parameters. The
lack of association in the present study may be attrib-
uted to the small sample size or the short duration of
follow-up. Another possible explanation is that the
effect of the AGT [-6G > A] polymorphism on cardiac
angiotensinogen concentration is unclear, in spite of
the association with the basal AGT transcription rate.
Regarding the AT1R [1166A > C] polymorphism,
although it was reported to be associated with collagen
Table 1. Characteristics and repolarization variables of 106 patients*
Baseline Yr 2 Yr 4
p
Yr 2 baseline Yr 4 baseline
Age (yr) 72.7 ± 4.1 74.7 ± 4.1 76.7 ± 4.1
Weight (kg) 61.3 ± 8.7 60.3 ± 8.8 60.3 ± 9.5 < 0.001 0.005
Height (cm) 162.1 ± 7.1 161.6 ± 7.0 161.7 ± 8.2 < 0.001 < 0.001
BMI (kg/m2) 23.3 ± 3.0 23.1 ± 3.1 23.1 ± 3.3 0.049 0.055
HR (bpm) 68.9 ± 9.6 69.0 ± 9.6 70.2 ± 11.6 0.783 0.177
SBP (mmHg) 125.0 ± 14.2 123.4 ± 14.1 125.6 ± 16.1 0.335 0.730
DBP (mmHg) 72.0 ± 8.8 72.4 ± 10.9 73.0 ± 12.7 0.832 0.361
LVMI (g/m2) 97.9 ± 25.4 101.2 ± 26.0 105.9 ± 29.7 0.171 0.001
QTc (msec) 422.4 ± 20.4 424.1 ± 21.0 428.9 ± 28.0 0.300 0.005
QTd (msec) 33.7 ± 11.6 38.1 ± 12.8 43.2 ± 12.0 < 0.001 < 0.001
QTcd (msec) 35.8 ± 12.4 40.7 ± 13.7 46.5 ± 13.5 < 0.001 < 0.001
Tpe (msec) 71.6 ± 13.4 77.6 ± 11.2 91.9 ± 12.3 < 0.001 < 0.001
Tpe/QT 0.181 ± 0.032 0.196 ± 0.028 0.231 ± 0.030 < 0.001 < 0.001
*Data are presented as mean±standard deviation. BMI = body mass index; HR = heart rate; SBP = systolic blood pressure; DBP = diastolic
blood pressure; LVMI = left ventricular mass index; QTc = corrected QT interval; QTd = QT dispersion; QTcd = QTc dispersion; 
Tpe = interval between the peak and end of the T wave; Tpe/QT = Tpe interval divided by QT interval.
type I synthesis and myocardial stiffness in hyperten-
sives, limited reports have discussed its relationship
with arrhythmia [21,26]. Although the C allele of this
polymorphism contributes to QTc prolongation in
subjects with end-stage renal disease [8], we did not
find a link between QT parameters and the AT1R
[1166A > C] polymorphism. A possible explanation
for this difference is the different enrolled popu-
lations. The dialysis patients reported by Raizada 
et al had different underlying diseases and showed
repolarization abnormalities. In addition, the effect of
the AT1R [1166A > C] polymorphism on cardiac RAS
activity is unclear. The lack of association in the pres-
ent study may be attributed to the small sample size
or the short duration of follow-up. With regard to 
the TDR-related parameters, investigations of other
genotypes, such as the polymorphism in the KCNQ1
gene identified by Ozawa et al, may further clarify
the genetic effects on these parameters in this longi-
tudinal cohort [15].
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Table 2. Different AT1R genotypes, clinical characteristics and repolarization variables*
AT1R genotype CC CA + AA
p
Number 92 13 + 1
Age (yr) 72.4 ± 4.1 74.2 ± 3.5 0.124
Weight (kg) 60.7 ± 8.8 64.7 ± 7.6 0.201
Height (cm) 161.8 ± 7.3 164.4 ± 5.2 0.117
BMI (kg/m2) 23.2 ± 3.1 24.0 ± 2.7 0.404
HR (bpm) 69.3 ± 9.8 66.0 ± 7.8 0.230
SBP (mmHg) 124.3 ± 14.2 129.4 ± 13.5 0.216
DBP (mmHg) 71.7 ± 8.9 73.6 ± 8.5 0.451
LVMI (g/m2) 96.3 ± 23.5 106.4 ± 35.7 0.167
QTd (msec)
Baseline 34.3 ± 11.8 29.7 ± 9.8 0.174
Yr 2 38.6 ± 13.2 35.1 ± 9.4 0.238
Yr 4 43.5 ± 11.9 41.4 ± 13.1 0.547
Yr2−0 4.3 ± 9.9 5.4 ± 11.7 0.716
Yr4−0 9.3 ± 10.4 11.7 ± 15.8 0.446
QTcd (msec)
Baseline 36.6 ± 12.6 31.0 ± 10.2 0.115
Yr 2 41.3 ± 14.2 36.8 ± 8.8 0.122
Yr 4 46.9 ± 13.6 43.9 ± 13.3 0.437
Yr2−0 4.7 ± 10.7 5.8 ± 12.7 0.707
Yr4−0 10.4 ± 12.1 13.0 ± 16.8 0.481
Tpe (msec)
Baseline 71.8 ± 13.4 70.6 ± 14.4 0.762
Yr 2 77.9 ± 11.6 75.5 ± 8.8 0.453
Yr 4 91.8 ± 12.6 92.8 ± 10.0 0.792
Yr2−0 6.2 ± 11.3 4.9 ± 9.4 0.693
Yr4−0 20.1 ± 13.0 22.2 ± 18.1 0.593
Tpe/QT
Baseline 0.181 ± 0.031 0.178 ± 0.038 0.677
Yr 2 0.197 ± 0.027 0.189 ± 0.031 0.348
Yr 4 0.231 ± 0.031 0.231 ± 0.025 0.935
Yr2−0 0.015 ± 0.029 0.012 ± 0.023 0.648
Yr4−0 0.049 ± 0.034 0.054 ± 0.042 0.653
*Data are presented as mean ± standard deviation. AT1R = angiotensin II type 1 receptor; BMI = body mass index; HR = heart rate;
SBP = systolic blood pressure; DBP = diastolic blood pressure; LVMI = left ventricular mass index; QTd = QT dispersion; QTcd = corrected
QT interval dispersion; Tpe = interval between the peak and end of the T wave; Tpe/QT = Tpe interval divided by QT interval; 
Yr2−0 = QT variable prolongation at year 2 minus baseline; Yr4−0 = QT variable prolongation at year 4 minus baseline.
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Study limitations
There are two limitations to this study. Firstly, 87 (45%)
patients were lost to follow-up in the overall cohort.
However, we found that there was no statistical sig-
nificance in the baseline characteristics of age, sex,
height, weight, BMI, LVMI, and systolic and diastolic
blood pressures between subjects who completed the
4-year follow-up and those who did not. Since these
87 subjects were excluded from our analysis from the
very beginning, our results should not be biased due
to follow-up losses. Secondly, we had a relatively small
sample size and only studied two genes, which may
not provide enough power to investigate genes with
minor effects.
CONCLUSION
This study shows that the AGT [-6G > A] and AT1R
[1166A > C] polymorphisms do not influence repolar-
ization parameters in this Chinese population in
Taiwan, and so are not suitable markers to identify
Table 3. Different AGT G-6A genotypes and repolarization variables*
AGT genotype AA GA + GG
p
Number 71 32 + 3
Age (yr) 72.3 ± 4.3 73.3 ± 3.5 0.241
Weight (kg) 61.1 ± 8.7 61.5 ± 8.8 0.844
Height (cm) 161.8 ± 7.0 162.9 ± 7.3 0.449
BMI (kg/m2) 23.4 ± 3.0 23.2 ± 3.2 0.821
HR (bpm) 67.8 ± 8.8 71.2 ± 10.9 0.086
SBP (mmHg) 123.6 ± 14.6 127.7 ± 13.1 0.164
DBP (mmHg) 71.8 ± 8.8 72.3 ± 9.0 0.804
LVMI (g/m2) 94.5 ± 21.7 104.0 ± 31.1 0.112
QTd (msec)
Baseline 34.1 ± 12.6 32.5 ± 9.5 0.490
Yr 2 38.7 ± 12.7 36.9 ± 13.1 0.487
Yr 4 43.6 ± 12.1 42.5 ± 12.0 0.650
Yr2–0 4.5 ± 10.7 4.3 ± 9.0 0.932
Yr4–0 9.4 ± 12.3 9.9 ± 8.4 0.794
QTcd (msec)
Baseline 36.1 ± 13.4 35.2 ± 10.3 0.721
Yr 2 41.6 ± 13.8 38.9 ± 13.5 0.344
Yr 4 46.5 ± 12.5 46.6 ± 15.5 0.969
Yr2–0 5.4 ± 11.7 3.6 ± 9.2 0.435
Yr4–0 10.4 ± 13.1 11.4 ± 12.2 0.698
Tpe (msec)
Baseline 72.4 ± 14.1 70.1 ± 12.0 0.417
Yr 2 78.0 ± 10.8 76.7 ± 12.1 0.584
Yr 4 92.0 ± 12.3 91.8 ± 12.5 0.919
Yr2–0 5.7 ± 12.1 6.7 ± 8.5 0.668
Yr4–0 19.7 ± 15.1 21.7 ± 10.5 0.429
Tpe/QT
Baseline 0.181 ± 0.035 0.180 ± 0.027 0.880
Yr 2 0.197 ± 0.028 0.194 ± 0.028 0.616
Yr 4 0.230 ± 0.031 0.232 ± 0.028 0.750
Yr2–0 0.015 ± 0.029 0.014 ± 0.024 0.744
Yr4–0 0.049 ± 0.038 0.052 ± 0.028 0.681
*Data are presented as mean ± standard deviation. AGT = angiotensinogen; BMI = body mass index; HR = heart rate; SBP = systolic
blood pressure; DBP = diastolic blood pressure; LVMI = left ventricular mass index; QTd = QT dispersion; QTcd = corrected QT interval
dispersion; Tpe = interval between the peak and end of the T wave; Tpe/QT = Tpe interval divided by QT interval; Yr2−0 = QT variable
prolongation at year 2 minus baseline; Yr4−0 = QT variable prolongation at year 4 minus baseline.
individuals susceptible to changes in these parame-
ters. Further studies are needed to find risk factors
predisposing individuals to prolongations of these
repolarization parameters.
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